Clinical Trial Management Software Development

Trial configuration covering study arms, visit schedules, inclusion and exclusion criteria, and randomisation schemes aligned to ICH E6(R3) Good Clinical Practice requirements. Protocol amendment management updates visit schedules and eligibility criteria across all active sites when a protocol version is approved -- so coordinators at every site are working from the current criteria, not a version they retrieved from an email attachment three months ago.

CDISC CDASH data standards are applied to the data collection structure where applicable, ensuring that fields captured in the CTMS align with the standard data collection framework used by EDC systems and expected in FDA and EMA regulatory submissions. IVRS and IWRS integration handles randomisation assignment for blinded trials -- the CTMS records the randomisation event without exposing treatment allocation, maintaining blind integrity at the operational level.

Investigational product management covers dosing schedule, storage requirements, and dispensing record structure. Each dispensing event is recorded against the patient visit so the IP accountability record required under GCP is maintained without a separate paper log. Study calendar view shows visit windows, required assessments per visit, and allowed deviation ranges so coordinators can identify in advance whether an upcoming visit is at risk of a protocol deviation before it occurs. Protocol version history makes the criteria and schedule active at any point in the trial retrievable in seconds during an inspection -- not recoverable from a shared drive folder with seven versions of the protocol document.

Site qualification and initiation tracking from feasibility through IRB or IEC approval, regulatory submission, and site activation. The site initiation visit (SIV) workflow captures the visit date, the investigator staff trained, the materials reviewed, and the activation decision -- with the monitoring report generated and approved in the system rather than filed as a Word document in a shared drive. Site initiation visit automation also triggers the delegation of authority log setup for the investigator team at each newly activated site.

Investigator and study staff records include role assignments, ICH E6-required training records, and delegation of authority entries. The delegation log captures who is authorised to perform each protocol procedure at each site, with dates effective and superseded -- the record an inspector expects to see demonstrating that every procedure was performed by appropriately authorised and trained staff.

Regulatory document collection covers IRB or IEC approval letters, FDA Form 1572, financial disclosure forms, investigator CVs, and laboratory normal ranges -- with expiry tracking and renewal reminders so the sponsor's TMF coordinator does not discover an expired IRB approval during a routine monitoring visit. Site performance dashboard shows enrolment count against target, visit compliance rate, open query count, deviation frequency, and monitoring visit schedule by site. Sites falling below enrolment targets or above expected deviation rates surface automatically in the sponsor's performance view rather than requiring a manual review of each site's status report.

Screening log with screen fail reason capture and eligibility criteria verification against the current protocol version. Every screen failure is recorded with the specific exclusion criterion that applied so screen failure analysis by criterion is available without manual tabulation. Informed consent tracking records the consent version, the date consent was obtained, and the staff member who obtained it -- the record ICH E6 requires to demonstrate that consent was properly administered before any study procedures began.

Patient-reported outcome (ePRO) integration supports electronic collection of patient diaries, symptom questionnaires, and quality-of-life instruments via BYOD (the patient's own smartphone) or site-provided devices. ePRO completion rates and overdue diary alerts are visible in the patient tracking view alongside visit compliance so coordinators have a complete picture of data completeness for each patient.

Enrolment status by site and study-wide shows current count against target with projection to trial completion based on current enrolment rate. Visit scheduling calculates allowed visit windows from the protocol calendar -- the system tells the coordinator the permitted date range for each upcoming visit given the previous visit date, rather than requiring manual window calculation. Visit compliance tracking flags overdue visits and identifies lost-to-follow-up patients based on missed contact attempts and visit non-attendance. Withdrawal and early termination recording captures the reason in a structured classification -- adverse event, withdrawal of consent, investigator decision, or protocol deviation -- for inclusion in safety reports and the statistical analysis dataset.

Deviation capture linked to the patient record, the specific protocol section violated, and the visit where the deviation occurred. Each deviation record includes the description of what occurred, the date identified, the date of the event, and whether the deviation affected patient safety or data integrity -- the fields regulators look at first during an inspection. SAE (Serious Adverse Event) expedited reporting workflow is integrated into the deviation module: events meeting the SAE criteria trigger a dedicated reporting workflow with 15-day and 7-day reporting timeline tracking to FDA, EMA, or both, depending on the trial's regulatory jurisdiction. The system flags overdue SAE reports before the submission deadline passes.

Deviation classification by severity -- minor, major, or important protocol deviation -- follows the classification scheme defined in the study's deviation management plan. The classification requires review and sign-off from the assigned medical monitor or sponsor representative before the deviation is finalised, with the sign-off recorded in the audit trail under 21 CFR 11.10(e) requirements. CAPA (Corrective and Preventive Action) assignment tracks the action owner, the planned resolution date, and the effectiveness review outcome.

Deviation trend reporting by site, investigator, category, and protocol section surfaces patterns before they become inspection findings. A site with three consent-related deviations in 60 days is a pattern the sponsor needs to address through re-training -- the trend dashboard identifies this before the monthly monitoring report would have flagged it. Sponsor and CRO review workflows track approval status and response documentation for each deviation, with the full review history stored against the deviation record.

Integration with EDC systems -- Medidata Rave, Veeva Vault EDC, and OpenClinica -- so visit data entered in the EDC is reflected in the CTMS without dual entry. The integration eliminates the discrepancy risk that occurs when enrolment counts in the CTMS and the EDC diverge because one system was updated and the other was not. eCRF validation rules (range checks, cross-field logic) defined in the EDC are respected at the integration boundary -- the CTMS does not import data that fails EDC validation and surfaces rejected records for coordinator review.

CDISC SDTM and ADaM submission datasets are referenced as the target data structure for regulatory submission to FDA and EMA eSub systems. The CTMS operational data is structured to align with CDISC CDASH collection standards at the point of capture, reducing the transformation work required when producing SDTM datasets from the collected data. Data reconciliation alerts fire when the EDC enrolment record and CTMS patient record are inconsistent -- for example, when a patient is marked enrolled in the EDC but remains in screening status in the CTMS.

Database lock workflow tracking covers query resolution status per site, data freeze confirmation, and lock status -- replacing the email chain that typically manages the lock process. Each site's readiness for database lock is visible in a single status view so the data management team does not need to contact each site coordinator individually to confirm query closure. Open queries from the EDC appear in the coordinator's operational dashboard alongside upcoming visit schedules so coordinators see both operational and data tasks in one workspace rather than switching between the CTMS and the EDC query management view.

Trial master file (TMF) index aligned to the ICH E6(R3) essential document requirements and the industry-standard TMF Reference Model. The TMF structure in the CTMS maps every document type to its required location in the TMF index so completeness can be measured objectively against a defined standard rather than against someone's recollection of what should be there. Document version control with upload, review, and approval workflow ensures that only the current approved version of each document is presented to an inspector while previous versions remain accessible with their approval history.

21 CFR Part 11 electronic records and signatures compliance is built into the document management layer. Electronic signatures for documents requiring sponsor or investigator sign-off are implemented with the authentication and non-repudiation controls required under 21 CFR 11.100 -- a signer must authenticate with their credentials before the signature is applied, and the signature record captures the signer's name, date, and the meaning of the signature (approved, reviewed, certified). The audit trail required under 21 CFR 11.10(e) captures every system action -- document upload, approval, deviation entry, enrolment change, and user access event -- with user identification, timestamp, and the previous value where a record was changed.

EU Annex 11 requirements for computerised systems are addressed through system access controls, audit trail completeness, and the change control record. Inspection readiness checklist identifies missing or expiring TMF documents before an audit -- not as a one-time check but as a continuously maintained completeness score by TMF section and site. TMF health reporting shows overall completeness percentage, documents missing by category, and documents expiring within 30 days so the TMF coordinator has an ongoing operational view rather than a pre-inspection scramble.